New financing will enable Atomwise to further scale the largest artificial intelligence (AI)-driven drug discovery portfolio in history and expand $5 billion+ deal pipeline for small molecule drug ...
Cross-pacific investor B Capital Group has increased its fund to $181 million, according to a regulatory filing. The fund, B Capital Fund LP, held a $143.6 million first close a year ago.